Vinaora Nivo Slider

The Cardno ChemRisk View

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
Posted by on in Policy/Regulatory Support
  • Font size: Larger Smaller
  • Hits: 4160

FDA's Update on BPA

Posted on behalf of the author, Whitney Christian, Ph.D.


On December 5th after a four-year review of over 300 scientific studies, the Food and Drug Administration (FDA) announced that the levels of BPA found in foods are safe. This announcement was based on new studies focusing on the developmental effects and metabolism of BPA. One study conducted by FDA toxicologists involved administering pregnant rats with 100 to 1,000 times more BPA than humans ingest in their food on a daily basis, determining the amount transferred to the unborn offspring, which was shown to be "so low it could not be measured." In addition, recent studies have shown that 99 percent of ingested BPA is metabolized so quickly into an inactive form that no harm would be expected.

Mr. John Rost, the president of the North American Metal Packaging Alliance, and Mr. Steven Hughes, the manager of the American Chemistry Council's Polycarbonate/BPA Global Group both stated that the FDA's conclusion support the safety and eliminate concerns of BPA's use in food containers and packaging. However, the FDA said it will continue to study BPA, and several studies being conducted by the National Toxicology Program, the National Institute for Occupational Safety and Health, and the National Institute of Environmental Health Sciences are currently underway.

Rate this blog entry:

Ms. Luda Kopelovich is a Senior Associate Health Scientist with Cardno ChemRisk. She is a graduate of the University of California, Davis where she earned a bachelor’s of science degree in Neurobiology, Physiology, and Behavior, and also a bachelor’s of art degree in Russian.  She received her MPH from University of California, Berkeley in 2015.  At Cardno ChemRisk (formerly ChemRisk, LLC), Ms. Kopelovich is regularly involved in litigation support, literature reviews, and exposure assessment. Her training includes risk assessment, dose reconstruction and evaluation, and environmental and occupational epidemiology. Additionally, she has been involved with assessing occupational, environmental, and consumer exposure to various chemicals, including asbestos, silica, diacetyl, benzene, toluene, and dibutyl phthalate.

The Cardno ChemRisk View

We're glad you decided to check us out.

Cardno ChemRisk is a respected scientific consulting firm headquartered in San Francisco with locations and consultants across the U.S. While our website provides a formal look at our capabilities, the Cardno ChemRisk View provides an informal voice too. Various Cardno ChemRisk consultants will be sharing news and views about current trends, happenings and methodologies in the industry. We’ll also highlight activities of interest at Cardno ChemRisk, within confidentiality restrictions of course.

The intent is to keep you informed and enable productive conversations, so please join in and get to know our staff and what makes our people unique. We are enthusiastic about the blogging experience and hope you will return often to learn and share. Stay tuned by subscribing to our blog or clicking on the RSS feed.





Cardno ChemRisk View Subscribers